Sector Update: Healthcare Stocks Edge Higher Premarket Friday

MT Newswires Live09-25 21:19

Healthcare stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.5%.

STAAR Surgical (STAA) shares were up more than 2% after the company said its board approved a share repurchase program allowing the company to buy back up to $50 million of its outstanding common stock.

Nektar Therapeutics (NKTR) stock was up more than 3% after the company said in a filing that a jury awarded it $90 million in damages against Eli Lilly (LLY), finding that Lilly breached the implied covenant of good faith and fair dealing under an agreement related to the development and commercialization of rezpegaldesleukin.

Fate Therapeutics (FATE) has been awarded a $15 million grant from the California Institute for Regenerative Medicine to support its clinical development of a phase 2 trial for FT819, a potential treatment for patients with moderate-to-severe systemic lupus erythematosus with lupus nephritis, the company said. Fate Therapeutics shares were up nearly 2% premarket.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment